Latest News

Mining cancer genome data provides treatment clues

There is an enormous amount that we do not understand about the fundamental causes and behavior of cancer cells, but at some level, experts believe that cancer must relate to DNA and the genome. In their ....

Featured White Paper

Multiple Myeloma and Next-Generation Sequencing

The diagnosis and treatment of multiple myeloma has entered a new knowledge cycle, where Next-Generation Sequencing (NGS) is helping to predict therapy response, allowing for better risk stratification and tailored treatment based on genomic profiles. To access the white paper, please click here.

Biomarkers

Advantages and Limitations of Current Biomarker Research: From Experimental Research to Clinical Application.

Biomarkers are indispensable tools for screening, diagnosis, and prognosis in cardiovascular diseases and their clinical application increases steadily. As cardiovascular diseases include various path ....

Decision Algorithms

Circulating Tumor Cells as Cancer Biomarkers in the Clinic.

It is believed that the development of metastatic cancer requires the presence of circulating tumor cells (CTCs) , which are found in a patient’s circulation as rare abnormal cells comingled wit ....

Product News

Markers differentiate viral and non-viral causes of systemic inflammation

SEATTLE. Immunexpress, Inc., a molecular diagnostic company with the first FDA cleared host response assay for suspected sepsis patients, today announced the publication, in Scientific Reports, of dat ....

Imaging

Hybridization chain reaction: a versatile molecular tool for biosensing, bioimaging, and biomedicine.

Developing powerful, simple and low-cost DNA amplification techniques is of great significance to bioanalysis and biomedical research. Thus far, many signal amplification strategies have been develope ....

Omics

Early detection: the impact of genomics.

The field of genomics has shifted our view on disease development by providing insights in the molecular and functional processes encoded in the genome. In the case of cancer, many alterations in the ....

Pipeline News

Daiichi Sankyo Initiates Phase 1/2 Study of Novel Antibody Drug Conjugate U3-1402 in Patients with HER3-Positive Metastatic or Unresectable Breast Cancer

TOKYO. Daiichi Sankyo Company, Limited announced today the initiation of a three-part open-label phase 1/2 study in Japan with U3-1402, a novel HER3-targeting antibody drug conjugate, in patients with ....

Issued Patents

Blood Markers For Diagnosing Epithelium Derived Cancers And Monoclonal Antibodies Thereof

The present invention provides uses of cytokeratins as markers for diagnosing epithelium derived cancers. The present invention provides cancer-related epitopes of cytokeratins and monoclonal antibodi ....

Patent Applications

Dna-decorated Graphene Chemical Sensors

The present invention provides a broad response single-stranded DNA-graphene chemical sensor device. The present invention also provides methods for improving the ability of graphene to work as a chem ....

Bioinformatics

Emerging technologies for prediction of drug candidate efficacy in the preclinical pipeline.

The pharmaceutical industry is tackling increasingly complex multifactorial diseases, resulting in increases in research & development (R&D) costs and reductions in the success rates for drug candidat ....

Funding News

Biocept announces pricing of $9.3 million financing

SAN DIEGO. Biocept, Inc., a leading commercial provider of clinically actionable liquid biopsy tests designed to improve the outcomes of cancer patients, today announced that it has entered into secur ....

Sensors and Wearables

Integrating diverse kinds of data key to precision health

STANFORD. Environmental, behavioral and social data could help researchers and clinicians prevent disease in whole populations — not just diagnose and treat disease — according to speakers at Stan ....

Recruiting Trials

Measuring Cell Free DNA During the Course of Treatment for Esophageal Cancer as a Marker of Response and Recurrence

To prospectively collect blood and tumor tissue from esophageal cancer patients to identify specific esophageal cancer mutations that can be measured in the blood (cell free DNA) during the cour ....